IRCT20191007045008N1招募中1 期
The evaluation of tissue-engineered adipose-derived mesenchymal stem cells for wound healing in diabetes
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 45 years（—）
- 性别
- All
入选标准
- •Signature of informed consent
- •Grade 1 or 2 wound on the Wagner Scale
- •With diagnosis of diabetic or other chronic wound
- •Female or male patient aged 15-45
- •Not pregnant
排除标准
- •Patients with a history of uncontrolled disease
- •Subjects with cancerous or pre-cancerous lesions in the area to be treated
- •Patient with working activity who cannot be on sick-leave during the study period
- •Known immunosuppressive disease, e.g. HIV infection, or hepatitis B or C infection
研究者
相似试验
招募中
1 期
Evaluation of the effect of SVF cells and nanofat for autologous fibroblast function in facial rejuvenatioIRCT20200127046282N30Tehran University of Medical Sciences10
进行中（未招募）
不适用
A clinical evaluation of adipose derived Regenerative cells in the treatment of patients with brEast deformities post Segmental breast resection (lumpectomy) with Or without Radiation therapy. A phase IV post market study – the RESTORE 2 trialEvaluación clínica de células regenerativas derivadas de tejido adiposo para el tratamiento de pacientes con deformidades mamarias tras mastectomia segmentaria (cuadrantectomia) con o sin radioterapia. Un ensayo fase IV de farmacovigilancia – Ensayo RESTORE -2 - RESTORE-2Pacientes con deformidades mamarias tras mastectomía segmentaria (cuadrantectomía) con o sin radioterapiaEUCTR2007-007956-33-ESCytori Therapeutics Inc70
进行中（未招募）
1 期
Safety and Efficacy of Mesenchymal Stromal Cells Derived from Adipose Tissue of Non-related Donors in Patients with The Butterfly Disease: Clinical Trial Phase I/IIEUCTR2020-002936-55-CZMasarykova univerzita15
尚未招募
1 期
Adipose-derived mesenchymal stem cell conditioned media in combination with crosslinked-hyaluronic acid for skin rejuvenatioIRCT20230324057772N2Tehran University of Medical Sciences35
已完成
2 期
The efficiency of Cell therapy for Werdnig Hoffman patientsWerdnig Hoffman.Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]IRCT2015073023417N1Vice chancellor for research, Tehran University of Medical Sciences10